UIS3

UIS3 (PF3D7_1302200) is a Plasmodium parasitophorous vacuolar membrane (PVM) protein that is essential for early liver-stage development, acting at the parasite-host interface to permit intrahepatic survival and progression to blood-stage infection (PMID:15580261, PMID:18577521). Genetic ablation of UIS3 does not block hepatocyte invasion or parasitophorous vacuole formation but arrests development shortly thereafter, with P. yoelii uis3(-) parasites failing to persist beyond ~40 hours post-infection (PMID:17624848). Its expression is controlled post-transcriptionally, being abolished in sporozoites lacking SAP1, placing UIS3 downstream of SAP1 in a regulatory pathway for infectivity genes (PMID:18466298). The soluble domain of P. falciparum UIS3 adopts a novel all-alpha-helical fold with a defined lipid-binding site that engages one molecule of phosphatidylethanolamine (PMID:18577521). Mechanistically, the P. berghei PVM protein UIS3 binds host LC3 through a non-canonical interaction with the surface LC3 normally uses for its LC3-interacting partners, thereby competitively blocking autophagy-mediated elimination of the parasite; small-molecule disruption of the UIS3-LC3 interface triggers autophagy-dependent parasite clearance (PMID:29109477, PMID:33214643). In the absence of UIS3, cell-autonomous restriction of P. berghei is mediated by host GABARAPs independently of canonical autophagy rather than by LC3 (PMID:33771680). An early model of UIS3 as a direct lipid-transfer partner of host liver fatty acid-binding protein (L-FABP) is not supported: NMR analysis detected no direct interaction between the UIS3 soluble domain and L-FABP (PMID:23169100).

1. 2004 High

   Establishing whether UIS3 has a non-redundant role in the parasite life cycle, the first knockout defined it as specifically required for the transition through the liver stage.

   Evidence Targeted gene knockout in P. berghei with in vivo rodent infection readout

   PMID:15580261

   Open questions at the time

   • Does not identify the molecular activity of UIS3
   • Does not localize the protein or define the arrest step
2. 2007 High

   To pinpoint where in liver-stage development UIS3 is required, deletion in a second species mapped the arrest to a post-invasion step after vacuole formation.

   Evidence Targeted gene deletion in P. yoelii with time-course quantification of liver parasite persistence

   PMID:17624848

   Open questions at the time

   • Does not explain the molecular cause of the ~40 h arrest
   • Does not connect the arrest to a specific host pathway
3. 2007 Medium

   Seeking a host binding partner to explain the liver-stage dependency, a screen proposed UIS3 engagement of host L-FABP as a route for lipid acquisition.

   Evidence Yeast two-hybrid plus L-FABP knockdown/overexpression with parasite growth readout in hepatocytes (P. falciparum, P. yoelii)

   PMID:17303141

   Open questions at the time

   • Direct UIS3-L-FABP binding later not confirmed by NMR (#7)
   • L-FABP growth effect not shown to require the UIS3 interaction specifically
4. 2008 Medium

   To place UIS3 in the regulatory hierarchy governing sporozoite infectivity, epistasis showed its expression depends on SAP1.

   Evidence SAP1 deletion in P. yoelii with RT-PCR and protein expression analysis of UIS3

   PMID:18466298

   Open questions at the time

   • Does not resolve whether regulation is transcriptional stability or translational
   • Does not establish a direct SAP1-UIS3 molecular link
5. 2008 High

   Defining UIS3 at atomic resolution revealed a novel all-alpha-helical fold with a lipid-binding pocket occupied by phosphatidylethanolamine, giving the first structural basis for a biochemical function.

   Evidence X-ray crystallography of the PfUIS3 soluble domain at 2.5 A with liposome lipid-binding assays; PVM localization reported alongside

   PMID:18577521

   Open questions at the time

   • Physiological role of PE binding in liver-stage development not established
   • Structure covers only the soluble domain, not the transmembrane context
6. 2013 Medium

   Testing the proposed lipid-transfer model, NMR found no direct UIS3-L-FABP interaction, revising the earlier host-partner hypothesis.

   Evidence Solution NMR (1H,15N HSQC) with residue-level interaction analysis of PfUIS3 soluble domain and L-FABP

   PMID:23169100

   Open questions at the time

   • Single-lab negative result
   • Does not exclude an indirect or full-length/membrane-dependent interaction
7. 2017 High

   Explaining how the parasite evades host defense, UIS3 was shown to bind host LC3 non-canonically and competitively block autophagy-mediated parasite elimination.

   Evidence Co-IP/pulldown, competition binding with LC3-interacting proteins, and uis3(-) survival assays in autophagy-proficient vs -deficient hepatocytes (P. berghei)

   PMID:29109477

   Open questions at the time

   • Structural basis of the non-canonical LC3 interface not fully resolved
   • Does not distinguish LC3 from other Atg8 subfamily members as the operative restriction factor
8. 2020 High

   To prove causality and test druggability of the evasion mechanism, small-molecule disruption of the UIS3-LC3 interface triggered autophagy-dependent parasite clearance.

   Evidence Docking screen, biophysical confirmation of C4-mediated disruption, and infection assays in autophagy-sufficient vs -deficient cells (P. berghei)

   PMID:33214643

   Open questions at the time

   • In vivo efficacy and selectivity of C4 not established
   • Does not address the GABARAP-dependent restriction arm
9. 2021 Medium

   Resolving which host pathway restricts UIS3-deficient parasites, genetic dissection showed restriction is GABARAP-dependent but autophagy- and LC3-independent, refining the evasion model.

   Evidence Panel of host autophagy-gene and Atg8-family knockouts with uis3(-) P. berghei growth quantification

   PMID:33771680

   Open questions at the time

   • Molecular mechanism of GABARAP-mediated restriction not defined
   • Whether UIS3 itself engages GABARAPs is not established

• It remains unresolved how UIS3's PE-binding activity and PVM residence mechanistically connect to its host LC3/GABARAP-directed immune evasion function, and whether these represent one integrated activity or separable roles.
• No structure of UIS3 bound to LC3
• Role of PE binding in vivo unknown
• Whether UIS3 directly engages GABARAPs is untested